ACAD officer sells shares to cover RSU taxes
ACADIA PHARMACEUTICALS principal accounting officer James Kihara exercised and vested equity awards and sold shares to cover taxes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACADIA PHARMACEUTICALS principal accounting officer James Kihara exercised and vested equity awards and sold shares to cover taxes. On May 1, 2026, he exercised 2,596 restricted stock units, receiving the same number of common shares at $0.00 per share. On May 4, 2026, 1,332 common shares were sold at a weighted average price of $21.79, with footnotes stating these mandatory sales were solely to cover withholding taxes and tax-related items in connection with the RSU vesting and intended to meet Rule 10b5-1(c) requirements. After these transactions, he directly held 29,129 common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,332 | $21.79 | $29K |
| Exercise | Restricted Stock Units | 2,596 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,596 | $0.00 | $0.00 |
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2. The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.79 to $21.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F4. The restricted stock units vest in four equal annual installments beginning May 1, 2024.
Key Figures
Key Terms
Restricted Stock Units financial
withholding taxes financial
Rule 10b5-1(c) regulatory
weighted average price financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ACAD (ACADIA PHARMACEUTICALS) officer James Kihara report in this Form 4?
What happened to James Kihara’s restricted stock units in this ACAD Form 4?
Does the ACAD Form 4 mention a Rule 10b5-1 trading plan for these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.